Upperton Pharma Solutions has been named a Champion Winner in the Small Molecule Dosage Form – International category at the 2025 CDMO Leadership Awards. The awards, presented by Outsourced Pharma and Life Science Connect, recognise contract development and manufacturing organisations (CDMOs)
Eckert & Ziegler SE and AtomVie Global Radiopharma Inc. have entered into a global supply agreement for Lutetium-177 chloride (n.c.a. Lu-177, Theralugand®). The deal ensures AtomVie has a steady supply of Theralugand® to support its contract manufacturing activities in radiopharmaceuticals. The agreement spans both
Bionova Scientific has announced a partnership with Bionique Testing Laboratories, appointing the contract research organisation (CRO) as its preferred provider for mycoplasma testing services. The collaboration aims to support the efficient manufacturing of biologics, reinforcing both companies’ roles within the bioprocess division
Wheeler Bio, a contract development and manufacturing organization (CDMO) specializing in antibody-based therapies, has secured $35 million in an oversubscribed Series A-1 financing round. The investment was led by Alloy Therapeutics and Echo Investment Capital, with additional support from Mitsubishi
Prasfarma has committed €32 million to expanding its facilities in Manlleu, reinforcing its focus on technological innovation and sustainability. The investment aims to enhance the production of oncology drugs while meeting the highest industry standards, including Annex I of Good Manufacturing
Alvotech, a global biotech company focused on biosimilar medicines, has announced the acquisition of Xbrane Biopharma AB’s R&D operations and the biosimilar candidate XB003. The deal, valued at approximately SEK 275 million (USD 27 million), strengthens Alvotech’s development capabilities and marks its entry into
Grifols has signed a strategic agreement with Inpeco, a leader in total laboratory automation technologies, to enhance transfusion medicine laboratories with advanced robotics and software solutions. The partnership aims to modernise lab operations, increasing efficiency and precision in blood screening and
John Chiminski, the former CEO of Catalent, has received the inaugural Lifetime Achievement in Pharma Services award at the CDMO Leadership Awards ceremony hosted by Life Science Connect during DCAT Week 2025. The awards was presented by Orientation Marketing’s Elliott
Flamma, a global contract development and manufacturing organisation (CDMO) specialising in small molecule APIs, has been named a winner in the 2025 CDMO Leadership Awards. The company was recognised in the Small Molecule API – Global category, reinforcing its position
Mabion has been named the Champion of the 2025 International CDMO Leadership Award in Biologics. The award, which recognises excellence in contract manufacturing, highlights the company’s commitment to delivering high-quality biologics development and manufacturing services to pharmaceutical and biotech clients. Organised
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
